Value-based health care frameworks for the health technology assessments of "omics" technologies: an international survey.

ABSTRACT:

Background

Despite omics technologies gaining traction in clinical settings, particularly in oncology, challenges persist in their widespread adoption due to the pre-requisite robust evidence supporting efficacy and cost-effectiveness. This study aims to explore the experiences of organizations working in the health technology assessment (HTA) field in evaluating omics technologies, with a particular focus on the adoption and application of specific assessment frameworks.

Methods

We conducted a global survey to gather insights into current practices and frameworks used in HTA evaluations of omics technologies.

Results

We gathered responses from thirty-nine participants representing organizations across twenty-nine countries and five continents. Among them, 51 percent

SUBMITTER: Osti T 

PROVIDER: S-EPMC12689241 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature